LONDON (Reuters) - A new, low-cost screening strategy could make it easier for poor countries to target and treat Chagas disease, a deadly parasite-borne condition found mainly in Latin America, according to a new study.Fighting the disease has traditionally focused mainly on spraying campaigns to kill the bug that carries the single-cell parasite causing Chagas disease, which affects an estimated 11 million people in the Americas.
